WuXi Biologics (Cayman) (WXXWY) Stock Price, Quote, News & History

Comments

WuXi Biologics (Cayman) Inc (WXXWY) Stock Price, Quote, News & History

WXXWYOTCPK

Trade with Public

$8.94

0.192.17%

Last update: Mar 16, 11:00 AM

OverviewNews Short Interest

Key Statistics

Open

$9.25

Volume / Avg.

7.58K / 61.21K

Day Range

$8.94 - $9.25

52 Wk Range

4.14 - 11.21

Market Cap

$18.45B

P/E Ratio

30.66

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent WuXi Biologics (Cayman) Inc News

PRO
WuXi Biologics And Bayer Earlier Announced An Acquisition Agreement On A Drug Product Plant in Germany

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

5.72B

Investing Cash Flow (TTM)

-4.10B

Financing Cash Flow (TTM)

-2.36B

Free Cash Flow (TTM)

1.76B

Capital Expenditure (TTM)

-3.96B

Net Change in Cash (TTM)

-735.67M

Valuation Metrics

Enterprise Value

$17.12B

PE Ratio (TTM)

30.66

PE Ratio (FWD)

21.10

PEG Ratio (TTM)

PS Ratio (TTM)

6.28

PB Ratio (TTM)

2.76

Earnings Yield % (TTM)

3.26%

Earnings Yield % (FWD)

4.74%

EV / EBITDA (TTM)

18.59

Price / EBITDA (TTM)

19.91

Price / Free Cash Flow (TTM)

71.59

Book Value / Share

$3.17

Company Debt

Total Debt

$2.73B

LT Debt

$185.14M

LT Debt Issuance (TTM)

$1.72B

LT Debt Repayment (TTM)

-$1.19B

Total Cash

$8.44B

Debt to Equity

0.11

Issuance of Debt (TTM)

$534.46M

Repayment of Debt (TTM)

-$1.19B

Key Statistics

Open

$9.25

Volume / Avg.

7.58K / 61.21K

Day Range

$8.94 - $9.25

52 Wk Range

4.14 - 11.21

Market Cap

$18.45B

P/E Ratio

30.66

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Life Sciences Tools & Services

WuXi Biologics is one of the largest global biologic global contract development and manufacturing organizations. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy WuXi Biologics (Cayman) (WXXWY) stock?

You can purchase shares of WuXi Biologics (Cayman) (OTCPK:WXXWY) through any online brokerage.

View our list of the best stock brokerages

Who are WuXi Biologics (Cayman) (WXXWY) competitors?

There are no as such competitors for WuXi Biologics (Cayman).

What is the forecast, or price target, for WuXi Biologics (Cayman) (WXXWY) stock?

There is no analysis for WuXi Biologics (Cayman) to provide a consensus price target.

What is the current price for WuXi Biologics (Cayman) (WXXWY)?

The stock price for WuXi Biologics (Cayman) (OTCPK: WXXWY) is $8.94 last updated March 16, 2026 at 11:00 AM EDT.

Does WuXi Biologics (Cayman) (WXXWY) pay a dividend?

There are no upcoming dividends for WuXi Biologics (Cayman).

When is WuXi Biologics (Cayman) (OTCPK:WXXWY) reporting earnings?

WuXi Biologics (Cayman) does not have any upcoming earnings scheduled.

Is WuXi Biologics (Cayman) (WXXWY) going to split?

There is no upcoming split for WuXi Biologics (Cayman).

What sector and industry does WuXi Biologics (Cayman) (WXXWY) operate in?

WuXi Biologics (Cayman) is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the OTCPK.

Key Statistics

Open

$9.25

Volume / Avg.

7.58K / 61.21K

Day Range

$8.94 - $9.25

52 Wk Range

4.14 - 11.21

Market Cap

$18.45B

P/E Ratio

30.66

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent WuXi Biologics (Cayman) Inc News

PRO
WuXi Biologics And Bayer Earlier Announced An Acquisition Agreement On A Drug Product Plant in Germany

Benzinga Newsdesk